Reading Between the Lines: Nuanced Decision-Making With Sustained Delivery Therapies - CME

CME

Title: Reading Between the Lines: Nuanced Decision-Making With Sustained Delivery Therapies

Description: Frequent intravitreal anti-vascular endothelial growth factor injections remain a major barrier to optimizing real-world outcomes in patients with retinal vascular disease. Sustained delivery therapies are redefining what is possible in retinal care. Using simulation-enhanced case studies, experts will highlight potential uses of new and emerging sustained delivery innovations, providing retina specialists and other ophthalmologists with realistic strategies for patient selection, safe integration, and long-term management in clinical practice.

Target Audience: This activity has been designed to address the educational needs of retina specialists and other ophthalmologists.

Learning Objectives

Describe key findings from clinical trials assessing new and emerging sustained delivery therapies
Select appropriate candidates for sustained delivery therapy based on patient and disease characteristics
Recognize strategies to mitigate the risk of adverse events with the use of the ranibizumab port delivery system (PDS)

Disclosures and Disclaimers: This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses. If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified. As an ACCME-accredited provider, Paradigm Medical Communications, LLC must ensure that its activities include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.

Accredited Providers

Commercial Support

Credit Information

Credit Type	Units / Unit Type	Board
AMA PRA Category 1 Credit	1 Credits	ACCME- Accreditation Council for Continuing Medical Education